A detailed history of Chevy Chase Trust Holdings, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Chevy Chase Trust Holdings, Inc. holds 294,506 shares of AMGN stock, worth $77.6 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares
294,506
Previous 298,426 1.31%
Holding current value
$77.6 Million
Previous $93.2 Million 1.77%
% of portfolio
0.29%
Previous 0.3%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$309.38 - $337.38 $1.21 Million - $1.32 Million
-3,920 Reduced 1.31%
294,506 $94.9 Million
Q2 2024

Jul 22, 2024

SELL
$262.75 - $319.31 $1.47 Million - $1.78 Million
-5,587 Reduced 1.84%
298,426 $93.2 Million
Q1 2024

May 03, 2024

SELL
$268.87 - $324.56 $695,028 - $838,987
-2,585 Reduced 0.84%
304,013 $86.4 Million
Q4 2023

Jan 24, 2024

SELL
$255.7 - $288.46 $361,304 - $407,593
-1,413 Reduced 0.46%
306,598 $88.3 Million
Q3 2023

Oct 23, 2023

SELL
$218.65 - $271.46 $1.46 Million - $1.82 Million
-6,693 Reduced 2.13%
308,011 $82.8 Million
Q2 2023

Jul 25, 2023

SELL
$214.27 - $253.37 $775,014 - $916,439
-3,617 Reduced 1.14%
314,704 $69.9 Million
Q1 2023

May 17, 2023

BUY
$225.79 - $275.2 $69.7 Million - $85 Million
308,772 Added 3233.55%
318,321 $77 Million
Q1 2023

May 15, 2023

SELL
$225.79 - $275.2 $69 Million - $84 Million
-305,390 Reduced 96.97%
9,549 $2.31 Billion
Q4 2022

Feb 09, 2023

SELL
$229.03 - $291.01 $4.75 Million - $6.04 Million
-20,742 Reduced 6.18%
314,939 $82.7 Million
Q3 2022

Nov 04, 2022

BUY
$224.46 - $253.15 $854,070 - $963,235
3,805 Added 1.15%
335,681 $75.7 Million
Q2 2022

Aug 10, 2022

SELL
$230.71 - $256.74 $3.74 Million - $4.16 Million
-16,210 Reduced 4.66%
331,876 $80.7 Million
Q1 2022

Apr 27, 2022

BUY
$219.27 - $242.57 $261,150 - $288,900
1,191 Added 0.34%
348,086 $84.2 Million
Q4 2021

Jan 31, 2022

SELL
$198.88 - $227.6 $2.14 Million - $2.45 Million
-10,762 Reduced 3.01%
346,895 $78 Million
Q3 2021

Oct 20, 2021

SELL
$212.27 - $248.7 $4.1 Million - $4.8 Million
-19,292 Reduced 5.12%
357,657 $76.1 Million
Q2 2021

Jul 20, 2021

SELL
$233.58 - $259.14 $4.85 Million - $5.38 Million
-20,762 Reduced 5.22%
376,949 $91.9 Million
Q1 2021

Apr 22, 2021

SELL
$221.91 - $258.6 $7.2 Million - $8.39 Million
-32,461 Reduced 7.55%
397,711 $99 Million
Q4 2020

Feb 12, 2021

SELL
$216.38 - $257.67 $3.69 Million - $4.39 Million
-17,031 Reduced 3.81%
430,172 $98.9 Million
Q3 2020

Nov 06, 2020

SELL
$234.65 - $260.95 $9.21 Million - $10.2 Million
-39,263 Reduced 8.07%
447,203 $114 Million
Q2 2020

Aug 14, 2020

SELL
$197.81 - $242.74 $6.28 Million - $7.7 Million
-31,723 Reduced 6.12%
486,466 $115 Million
Q1 2020

May 13, 2020

BUY
$182.24 - $241.7 $1.46 Million - $1.94 Million
8,033 Added 1.57%
518,189 $105 Million
Q4 2019

Feb 12, 2020

SELL
$189.21 - $243.2 $876,420 - $1.13 Million
-4,632 Reduced 0.9%
510,156 $123 Million
Q3 2019

Nov 20, 2019

SELL
$174.11 - $208.62 $1.3 Million - $1.56 Million
-7,458 Reduced 1.43%
514,788 $99.6 Million
Q2 2019

Aug 14, 2019

SELL
$166.7 - $195.41 $1.82 Million - $2.13 Million
-10,920 Reduced 2.05%
522,246 $96.2 Million
Q1 2019

May 13, 2019

SELL
$180.87 - $203.88 $1.33 Million - $1.5 Million
-7,347 Reduced 1.36%
533,166 $95.7 Million
Q4 2018

Feb 14, 2019

SELL
$178.4 - $208.25 $1.61 Million - $1.88 Million
-9,035 Reduced 1.64%
540,513 $105 Million
Q3 2018

Oct 23, 2018

SELL
$185.29 - $208.89 $5.36 Million - $6.05 Million
-28,942 Reduced 5.0%
549,548 $114 Million
Q2 2018

Aug 02, 2018

SELL
$166.05 - $186.51 $503,131 - $565,125
-3,030 Reduced 0.52%
578,490 $107 Million
Q1 2018

Apr 10, 2018

SELL
$169.43 - $198.0 $10.4 Million - $12.2 Million
-61,442 Reduced 9.56%
581,520 $99.1 Million
Q4 2017

Jan 22, 2018

SELL
$168.79 - $188.59 $5.99 Million - $6.69 Million
-35,480 Reduced 5.23%
642,962 $112 Million
Q3 2017

Nov 14, 2017

BUY
$167.29 - $191.0 $113 Million - $130 Million
678,442
678,442 $126 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Chevy Chase Trust Holdings, Inc. Portfolio

Follow Chevy Chase Trust Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chevy Chase Trust Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Chevy Chase Trust Holdings, Inc. with notifications on news.